Baxalta

FEIBA NF

Manufacturer:

Baxalta

Feiba Nf HCPCS:

J7198

HCPCS Code Descriptor:

Anti-inhibitor, per i.u.

Category:

J Code

Feiba Nf NDCs:

64193-0424-02, 64193-0423-02, 64193-0426-02, 64193-0425-02

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Feiba Nf CPT Codes:

Potential CPT administration codes for Feiba Nf can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

64193-0423-02

About Feiba Nf:

FEIBA NF is a Hematology drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J7198 is aligned to the drug FEIBA NF.

ACCESS PRICING AND MORE BY REGISTERING

J7198 Added Date:

January 1, 2000

J7198 Effective Date:

January 1, 2000

J7198 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Feiba Nf billing and coding information.
Feiba Nf patient assistance information can be found through Takeda Patient Support at the URL: https://www.feiba.com/us/hcp/for-your-patients#
FEIBA NF prescribing information can be found at the link below:
Information regarding FEIBA NF’s side effects can be found at MedlinePlus